Becton Dickinson (BDX) fundamentals: P/E, valuation, undervalued?
Becton Dickinson · Health Care · ref. ETF XLV · price $188.13
In short — Becton Dickinson trades at 32.9× earnings (P/E), 14.2× forward, with a net margin of 4.2 % and revenue growth of +5 %. Read: High P/E (P/E 33 (above average)).
Is Becton Dickinson stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$188.13+25.1% over range
Aug 28, 25low $138.67 · high $192Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
56% recommend buying · 9 analysts
Valuation : High P/E — P/E 33 (above average)
Valuation
32.9
P/E (price/earnings)
14.2
Forward P/E
—
PEG
2.1
Price/book (P/B)
$51.2B
Market cap
5.72
EPS
Profitability & growth
4.2 %
Net margin
+5 %
Revenue growth
-31 %
Earnings growth
$16.8B
Total debt
Becton Dickinson income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $18.9B | $1.7B | 9.0 % |
| 2023 | $19.4B | $1.4B | 7.4 % |
| 2024 | $20.2B | $1.7B | 8.5 % |
| 2025 | $21.8B | $1.7B | 7.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Becton Dickinson's P/E and is the stock undervalued? What's a good P/E?
Becton Dickinson's P/E is 32.9 (forward 14.2). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "High P/E".
Is Becton Dickinson profitable?
Becton Dickinson has a net margin of 4.2 % (EPS 5.72). The company is profitable.
Is BDX stock expensive?
Our read: "High P/E" — P/E 33 (above average). Cross-check with growth and sector.
💬 A question about Becton Dickinson? The JPI assistant answers using our backtest data.
Keep exploring Becton Dickinson